scavenger receptor type B (SRB ) functions as a mediator of cholesterol transfer between HDL particles and cells 2) . SRB also has binding capacity to apolipoprotein B (apoB) containing lipoproteins, including low density lipoprotein (LDL) and very low density lipoprotein (VLDL), and is implicated in the removal of such lipoproteins from the blood circulation 3) Introduction High-density lipoprotein (HDL) plays a crucial role in reverse cholesterol transport from the peripheral tissues to the liver and is postulated to have antiatherogenic effects via this function 1) . In this process, seems to be involved in antiatherogenic functions; however, from in vitro studies using human macrophages and in vivo experiments using mouse models, macrophage SRB has been shown to play a dual role in atherogenesis; namely, the development of initial fatty streak lesions is induced by facilitation of the uptake of atherogenic lipoproteins, such as LDL and VLDL, thus inducing foam cell formation 5) , through SRB function, and conversely the function in cholesterol efflux to HDL via SRB expression protects the arterial wall from an extensive lipid accumulation at a later stage of atherosclerotic evolution 4) . Considering these SRB / roles in lipid transfer between the cells and lipoproteins [1] [2] [3] [4] , it is considered that SRB / may be a modulator of lipid accumulation in the arterial wall in collaboration with lipoproteins.
Atherosclerosis begins with serum lipids permeating into the subendothelial space, followed by the infiltration of monocyte-derived macrophages into the subendothelial space and the migration of smooth muscle cells (SMCs) into the intima from the media 6) . The macrophages and SMCs become foam cells in the arterial intima, and the increase of these cells and extracellular lipid accumulation in the intima leads to the progression of atherosclerosis 6) . In addition, SMCs and monocyte-derived macrophages in the arterial intima are directly involved in lipid metabolism as well as SRB / expression through the production of proteins having a role in cholesterol transfer or lipid deposition, such as apoJ, apoE, cholesteryl ester transfer protein (CETP), and secretory phospholipase A2s (sPLA2s) [7] [8] [9] [10] . In spite of a close relationship between intimal cells expressing SRB / and lipid-relating proteins, such as apolipoproteins, CETP and sPLA2s, the association of SRB / expression with the intracellular and extracellular distribution of these proteins in the human atherosclerotic aorta requires further clarification.
SRB is expressed in the endothelial cells, monocyte-derived macrophages and SMCs in the arterial wall 2, 11, 12) . SRB tissue expression is similar to SRB , but exhibits lower levels than SRB 2) ; however, the sequential change of distribution patterns of SMCs expressing SRB / in the whole process of atherosclerotic evolution has not yet been described.
From this background, we histopathologically examined the relationship between SRB / -expressing cells and the distribution of the four types of apolipoproteins, four types of sPLA2s, and CETP in atherosclerotic aortas. In addition, sequential changes in the density of SRB / -positive macrophages and SRB / -positive SMCs in the whole process of atherosclerosis development in human aortas were investigated.
Materials and Methods

Tissue Preparation
Eighty human aortic tissues were obtained from 20 autopsy cases aged 37 to 83 years (15 males and 5 females). The tissues were generous gifts from the patients' relatives who gave written agreement for usage in this study. All cases had died from cancer, pneumonia, or renal failure, without cardiovascular diseases. The specimens were taken from the thoracic and abdominal aortas and included various macroscopically evident atherosclerotic lesions as well as non-atherosclerotic portions. They were then fixed in 10% neutral-buffered formalin and embedded in paraffin. From each paraffin block, twenty thin sections (4 m-thick) were obtained, and two sections were stained with hematoxylin-eosin (HE) and elastic van Giesons (EVG) staining.
Classification of Lesion Types
In this study, the intimal lesion types were classified into four categories, types , , , and lesions according to the classification of the American Heart Association 6) with minor modification. Adaptive intimal thickening is generally composed of mild SMC proliferation, which contains a small number of macrophages, and the initial lesion contains an increased number of foamy macrophages in comparison to adaptive intimal thickening; however, it is difficult to discriminate adaptive intimal thickening from the initial lesion in one aortic tissue, because they are sometimes mingled in one region. For such a reason, aortic tissue exhibiting an adaptive intimal lesion type or initial lesion is defined as type lesion. Type lesion contains an aggregation of foamy cells, which corresponds grossly to a fatty streak. Type lesion (so-called preatheroma) contains extracellular lipid deposition with scattered lipid-laden cells, which is interpreted as an intermediate lesion between a fatty streak and atheroma. Type lesion (atheroma) contains a lipid core and a fibrous cap. In this study, 'normal' was designated as an intima with no atherosclerotic lesion and no fibrocellular thickening. The above classification was made by three pathologists (YI, MKM, and TI) through observation of sections with HE and EVG staining as well as immunostaining against -smooth muscle actin ( -SMA) and human macrophages.
Immunohistochemistry
Subserial thin sections were immunostained with rabbit polyclonal antibodies against human sPLA2-A, -, -and -using the EnVision kit (DakoCytomation, Carpinteria, CA. USA) 10) , goat antibody against apoA-, apoB and apoJ (Acris Antibodies GmbH, Hiddenhausen, Germany) using the LSAB method (DakoCytomation), rabbit antibody against SRB /B (Novus Biologicals Inc., Littleton, CO. USA) and mouse antibody against CETP (Chemicon International, Inc., Temecula, CA. USA) using the CSA-kit (DakoCytomation), and mouse antibody against apoE (Innogenetics NV, Gent, Belgium) using the EnVision kit (DakoCytomation) according to the manufacturer's instructions. Immunostaining against -SMA (clone 1A4; DakoCytomation) and human macrophages (clone HAM56; DakoCytomation) was also performed using the EnVision kit to identify SMCs and monocytes/macrophages in intimal lesions, respectively. For HAM56 immunostaining, deparaffinized sections were pretreated with 0.1% pronase (DakoCytomation) for 5 min.
The deparaffinized sections were incubated with antibodies against sPLA2s overnight at 4 , -SMA and HAM56 for 30 min at room temperature, and apoA-, apoB, apoE, apoJ, CETP, and SRB / for 2 hr at room temperature. After washing, they were reacted with the secondary antibody, and the reaction products were visualized by treating the slides with diaminobenzidine tetrahydrochloride (DAB Liquid System; DakoCytomation). To verify specificity, an additional section from each block was used as a negative control by omitting the primary antibody and replacing it with the corresponding normal mouse, goat or rabbit immunoglobulin. Double immunostaining with antibodies for -SMA and SRB / as well as HAM56 and SRB / was performed on sections from the same paraffin block of each lesion to determine the localization of SRB / in intimal cells. In brief, the sections were first immunostained with SRB / and visualized by DAB treatment. These sections were then reimmunostained with antibody for -SMA or HAM56 using EnVision System-AP (DakoCytomation) and visualized by treating the slides with a BCIP/NBT substrate system (DakoCytomation).
The extent of immunopositivity against SRB / , CETP, each apolipoprotein, and each sPLA2, in the stroma was arbitrarily graded into four categories using the following scale: , negative; , mildly positive;
, moderately positive; , severely positive. The immunopositivity of SRB / in -SMA or HAM56-positive cells was described as for a negative result and for a positive result.
The above semi-quantitative analysis was employed by three pathologists (YI, MKM, and TI) in a blinded manner, and the common grade point evaluated by two or three investigators was adopted.
Statistical Analyses
For statistical analyses, sections immunostained with three antibodies for SRB / , -SMA, and HAM-56 as well as double-immunostained sections were used. To assess the density of cells Because SRB / -positive cells were not recognized in the normal aorta, these analyses were performed for type , , , and lesions.
All statistical analyses were carried out using the StatView software package (Abacus Concepts, Berkeley, CA, USA). A p-value less than 0.05 was considered significant.
Results
The results of immunohistochemistry are summarized in Table 1 for the cells and Table 2 for the stroma. There was no difference in all expression patterns by age, but some differences were demonstrated by the lesion type. In addition, the distribution pattern and location of SRB / -positive SMCs and macrophages in each intimal lesion are summarized in Table 3 .
Normal Aorta
In the normal intimal stroma, all apolipoproteins and sPLA2s except for sPLA2-were sparsely and weakly found, but CETP was not detected. SRB / -positive cells were not recognized in the normal intima. Most of the medial SMCs were positive for SRB / , CETP, and sPLA2-A, -, -, and -. ApoA-, apoB, and apoE were not recognized in the medial SMCs. ApoA-, apoB, and CETP were not detected in the medial stroma, but apoE, apoJ, sPLA2-A, -, and -were detected in the lower third of the media, and sPLA2-was mildly scattered in all layers of the media. In the media, the distribution pattern of SRB / -positive SMCs was similar to the extracellular distribution of CETP, sPLA2-A, -, Type lesion (Fig. 1a − d) In the intima, a few macrophages were positive for SRB / , but SRB / was detected in many SMCs by double immunostaining. These SRB / -positive cells were scattered in the thickened intima. All proteins, except for apoA-, examined in this study were recognized in intimal cells. In the intimal stroma around SRB / -positive cells, apoA-, apoB, apoE, and sPLA2 -were moderately distributed, and CETP, apoJ, sPLA2-A, -, and -were mildly found. Medial SMCs just under the intimal lesions showed immunoreactivity for SRB / , CETP, apoJ, and sPLA2s, but not for apoA-, apoB, and apoE. In the medial stroma just under the intimal lesion, all apolipoproteins, sPLA2-, and -were moderately distributed, and CETP, sPLA2-A, and -were mildly scattered. CETP, apoB, apoE, and sPLA2-A were present in the medial cells or stroma of the upper two-third layers, in where SRB / -positive SMCs were abundantly distributed. In addition, apoA-, apoJ, sPLA2-, -, and -were expressed in the cells and stroma of all of the aortic layers.
Type lesion (Fig. 1e − h ) Double immunostaining for SRB / and -SMA demonstrated the distribution of SRB / -positive SMCs, including foamy SMCs in the intima around a fatty streak, and these SRB / -positive SMCs were scattered. The majority of cells immunopositive for both HAM56 and SRB / in the intima were foamy, and tended to aggregate in the central portion of a fatty streak. All proteins, except for apoA-, were expressed in cells constituting the intimal lesion. In the intimal stroma, CETP and sPLA2-A were mildly distributed; apoA-, apoB, apoE, and apoJ were extensively distributed; and sPLA2-and -were moderately detected. Thus, these lipid metabolismrelated proteins were expressed in the stroma of the intimal lesion around SRB / -positive cells.
The expression patterns of all proteins in the medial SMCs and stroma were similar to those in type lesions. The distribution of SRB / -positive cells in the media overlapped those of the other proteins in the stroma, but apoA-, apoB, and apoE were detected only in the upper half layer of the media.
Type lesion (Fig. 2a − d) :
SRB / was detected in many intimal cells, including foamy cells. By double immunohistochemistry, SRB / was expressed in both -SMA-positive cells and macrophages. SRB / -positive SMCs were mainly distributed in the surface area of raised lesions, but SRB / -positive macrophages were mainly observed in the central portion of the intimal lesion. In the intimal stroma, apoA-, apoB, apoE, apoJ, sPLA2-, and -were extensively distributed, and CETP, sPLA2-A, and -were moderately distributed. All proteins except for apoA-were expressed in the intimal cells to varying extents.
The medial SMCs just under the intimal lesions showed immunoreactivity for SRB / , CETP, sPLA2s, and apoJ, but apoA-, apoB, and apoE were absent in these cells. In the medial stroma, all proteins, except for SRB / , were detected in the upper third layer, and sPLA2-was expressed more extensively than the other proteins. ApoA-, apoB, and apoE were more extensively distributed in the upper half layer than the lower half layer of the media, and their distribution patterns were similar to that of SRB / .
Type lesion (Fig. 2e − j) All proteins were recognized in many foam cells around a lipid core. SRB / , CETP, apoE, apoJ, and sPLA2s were also expressed in intimal cells observed in the lesion. By double immunohistochemistry, SRB / -positive SMCs were mainly scattered in the fibrous cap and shoulder portion of a atheroma lesion. In contrast, SRB / -positive macrophages were mainly distributed in the area around the atheroma core. ApoA-, apoB, apoE, apoJ, sPLA2-, andwere widely expressed in the stroma of the intimal lesion, but sPLA2-was relatively restricted in the subendothelial space. All proteins were observed in a lipid core. The expression patterns of CETP, apolipoproteins, sPLA2-A, and -were similar to that of SRB / -positive cells in the intimal lesion.
In the media, SRB / , CETP, sPLA2-A, -, and -were uniformly expressed in SMCs. ApoJ and sPLA2-were found in SMCs distributed in the upper third of the media, but apoA-, apoB and apoE were not detected in SMCs in the media. In the medial stroma, CETP, sPLA2-A, -, and -were mildly or moderately scattered, but immunopositivity for all apolipoproteins was intense at the boundary between the intima and media. The distribution pattern of sPLA2-was a mottled in the medial stroma.
Statistical Analyses
The fluctuation of the density of SRB / -positive cells in the aortic intima with the progression of atherosclerosis is shown in Fig. 3a The density of SMCs was significantly greater in type than in the other types (p 0.05 by Schffe's F -test), and decreased with atherosclerotic development from type to (one-way ANOVA: p 0.0182). The density of SRB / -positive SMCs also decreased from type to , but the difference was not significant between the values of type and . In addition, the fluctuation pattern of the density of SRB / -positive SMCs from type to lesions was similar to that of SRB / -positive cells, as shown in Fig. 3b .
The density of SRB / -positive macrophages significantly increased from type lesion to type lesion (p 0.0113; one-way ANOVA) and was significantly greater in type lesions than in the other Immunorectivity of sPLA2-X is similar to that of apoJ. d. Double immunostaining using SRB / (brown) and human macrophage (blue) antibodies indicates SRB / expression in macrophages (arrows). e. In the aorta with type lesion, SRB / -positive cells are distributed in the shoulder portion of an atheroma lesion and in the media. f. Immunohistochemistry using human macrophage antibody indicated macrophage distribution in the shoulder portion of an atheroma lesion, similar to the distribution of SRB / . g. ApoB is recognized mainly in the atheroma core and intimal stroma. h. Immunoreactivity of sPLA2-V is similar to that of apoB. i. Double-immunostaining using SRB / (brown) and human macrophage (blue) antibodies indicates SRB / expression in macrophages (arrows) distributed in the shoulder portion adjacent to an atheroma lesion. j. Double immunostaining using SRB / (brown) and smooth muscle actin (blue) antibodies indicates SRB / expression in foamy SMCs in the intima. lesion types (Fig. 3c) ; however, the density of macrophages was significantly greater in type lesion than the other lesion types (p 0.027; one-way ANOVA).
Discussion
In the present study, SRB / -positive cells were detected in intimal lesions in all stages of atherosclerosis development. In addition, SRB / was expressed in both SMCs and monocytes-macrophages in the intima, and CETP, apolipoproteins, and sPLA2s were expressed in the intimal stroma around SRB / -positive cells in all lesion types. Although there were few SRB / -positive macrophages in the intimal lesions of types and , the density of these cells in the intima increased with the advance of atherosclerosis. In contrast, the density of SRB / -positive SMCs in the intimal lesions of types and was higher than that of SRB / -positive macrophages and decreased with atherosclerosis development. Considering previous reports on the function of these receptors 2, 8, 13, 14) together with the present results, it is suggested that both SMCs and macrophages commonly play both roles for the removal and/or deposition of lipids in the aortic intima through SRB / functions, and that macrophages contribute to lipid deposition in the advanced lesions more than SMCs. SRB / , a receptor for HDL 15) and LDL 16) , mediates the selective uptake of cholesteryl ester from these lipoproteins and the transport of cellular unesterified cholesterol to HDL 17) . Recent studies have shown that SRB is expressed only in macrophages in atherosclerotic lesions of the human aorta and coronary arteries 18) . On the other hand, the expression of SRB in vascular SMCs has been identified in the human cerebral arteries of normal brains and in brains with Alzheimer's disease 12) and in rat aorta 11) , but not in the SMCs of human aorta and coronary arteries 18) . In the present study, the majority of macrophages positive for SRB / in the intima exhibited foamy cells, as seen in previous reports 18) . In addition, SRB / was expressed in the medial SMCs mainly distributed in the upper third medial layer of the normal and atherosclerotic aortas as well as in the intimal SMCs of the aortas having adaptive intimal thickening and atherosclerotic lesions, and many SRB / -positive SMCs in the intima also exhibited the foamy cell type. These observations suggest that SMCs in a normal aorta and an aorta with an atherosclerotic lesion contribute to the selective uptake or efflux of cholesterol via the function of SRB / , the same as macrophages that are distributed in atherosclerotic lesions.
In the present study, CETP was widely distributed in the intimal stroma with various lesions as well as apolipoproteins. ApoA-circulates in the plasma as a constituent of HDL particles, and apoB as a constituent of LDL and VLDL particles 19) . From such characteristics of apoA-and apoB, the distribution of apoA-in the aortic wall is almost the same as that of HDL particles, and the distribution of apoB in the aortic wall is almost the same as the localization of LDL and/or VLDL particles. The colocalization of CETP and apoA-/B in the intimal lesion, as shown in the present results, therefore indicates that CETP colocalizes with HDL and apoB-containing lipoproteins in the aortic intima. On the other hand, CETP has a role in cholesteryl ester efflux from the extracellular compartments, damaged cells and macrophages 20, 21) and functions to transfer cholesteryl ester from apoA--containing HDL to apoB-containing lipoproteins 21, 22) , thus resulting in a redistribution of cholesteryl ester. In addition, apos A-, E and J function to remove excess cholesterol and phospholipids from the arterial intima 8, 13, 23) , and apos A-and E promote the efflux of cholesterol ester from cells through SRB function 14, 24) . In the present study, the distributions of apolipoproteins and CETP in the intima were similar to that of SRB / -positive cells. Considering the distribution patterns of CETP, apolipoproteins, and SRB / -positive cells in all lesions examined, SRB / -positive macrophages and SMCs in the intima contribute to the redistribution of excess cholesterol from the aortic wall to other tissues via the expression of SRB / .
The present results demonstrated that the distribution patterns of sPLA2s were similar to those of apoA-and apoB in the aortic wall. This finding indicates the colocalization of sPLA2s and HDL/LDL particles in atherosclerotic lesions; therefore, HDL and LDL found in the intimal lesions are considered to be modified through the hydrolytic function of sPLA2s for phosphatidylcholine on these lipoproteins 25) . sPLA2-modified HDL is a more efficient substrate for SRB -mediated selective uptake of cholesteryl ester than normal HDL 26) . In addition, sPLA2-modified lipoproteins can easily bind to proteoglycans 27, 28) and promote foam cell formation of macrophages 29, 30) . The similar distribution patterns of sPLA2s to those of apoA-and apoB in our results suggest that sPLA2s may function in lipid deposition in intimal cells through SRB expression and stroma in the entire process of atherosclerotic evolution.
In this study, the density of SRB / -positive cells in the intima decreased from type lesion up to type lesion, but significantly increased in type lesions. This decrease of SRB / -positive cells in the intima appears to be caused by a decrease of SRB / -positive SMCs, because the density of SRB / -positive SMCs in the intima decreased from type to type lesion. SMC apoptosis in the intima is generally induced by oxidized LDL 31) , and the density of apoptotic SMCs in the aortic intima increases with atherosclerotic development 32) . A decrease in the density of SRB / -positive SMCs may be due to an increase of apoptosis or necrosis of SMCs in intimal lesions. On the other hand, the present results demonstrated that the density of SRB / -positive macrophages was small in types and lesions but abruptly increased in types and lesions. In the intima exhibiting types and lesions, extracellular lipid deposition is observed accompanied with abundant oxidized LDLpositive cells 32) , and oxidized LDL induces SRB expression of monocyte-derived macrophages 33) . From these previous findings 32, 33) , it is considered that an increase of SRB / -positive macrophages may be caused by the induction of degenerated LDL, such as oxidized LDL in the intima. In fact, SRB / -positive macrophages were mainly distributed in the central area of intimal lesions with type and type , as shown in Table 3 .
The present results indicate that SMCs mainly help to remove excess lipid in early atherosclerotic lesions, such as types and lesions, through SRB / expression as well as the synthesis of apoJ and CETP 7, 9) , whereas macrophages act mainly in advanced lesions, such as types and lesions via SRB / function and apoE production 8) ; however, the foam cell formation of SMCs and monocyte-macrophages by SRB / function further leads to extracellular lipid deposition through their necrosis/apoptosis 32, 34) . It is therefore considered that both SMCs and macrophages are involved in both antiatherogenic and atherogenic roles via complicated interactions between SRB / and apolipoproteins, CETP, or sPLA2s. In addition, considering vascular wall relaxation induced by the interaction of HDL and SRB due to nitric oxide production 2) , an increase of SRB / -positive cells in the aortic wall with atherosclerosis evolution may also contribute to aortic wall relaxation in aortas with advanced intimal lesions.
